AAA. D. Astakhova

A. D. Astakhova

*This is an algorithmically generated author record based on publicly available information.

A. D. Astakhova has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessment of the prevalence of systemic lupus erythematosus in women with reproductive health problems in the Russian Federation. Results of the multicenter pilot PRISMA study

    by T. M. Reshetnyak, E. A. Trofimov, D. I. Abdulganieva, A. D. Astakhova, G. R. Enikeeva, N. V. Seredavkina, E. V. Zonova, O. V. Bugrova, M. V. Zlobin, A. A. Klimenko, et al.

    Objective: to assess the prevalence of systemic lupus erythematosus (SLE) in the Russian population of patients with reproductive health problems (RHP). Material and methods. Patients were enrolled in 2023–2024 at 15 clinical centers in 5 federal districts of the Russian Federation. Women referred by a gynecologist, reproductive specialist, or general practitioner to a rheumatologist to rule out a systemic autoimmune rheumatic disease (SARD) were included. The study comprised two visits: the first screening visit and the second (final, 2–6 weeks later) visit, during which SARD verification was performed. Descriptive statistics methods were used for data analysis. The frequency of features in two independent study groups was compared using χ2 (Pearson’s test), odds ratios with 95% confidence intervals. The association between antibody levels and clinical manifestations was assessed by constructing a regression model. Results and discussion. Of 631 women examined, 612 (97.0%) met the inclusion criteria; 19 women were excluded because they did not have RHP (infertility or pregnancy loss) and/or signs of SARD. Antinuclear factor (ANF) was determined in 590 of 612 women. ANF positivity was detected in 238 (40.3%) of 590 patients. Of these 238 women, antinuclear antibodies were detected in 71, and decreased complement component levels were found in 55 (C3 in 28 and C4 in 27). SARD was diagnosed in 71 (11.6%) cases: SLE in 27 (4.4%) (definite in 23 and probable/incomplete in 4), mixed connective tissue disease was newly diagnosed in 36 (5.9%), Sjцgren’s disease in 4 (0.7%), and systemic sclerosis in 4 (0.7%). Among ANF-positive patients with RHP, 167 (70.2%) of 238 had no SARD. Conclusion. In this multicenter pilot study, the frequency of SLE in the Russian population among women with RHP was 4.4% (27 of 612 women), and the overall frequency of SARD was 11.6% (71 of 612). ANF positivity occurred more than three times (40.3%) more often than newly diagnosed SARD cases, indicating the need for further studies to clarify the reasons for ANF occurrence in women of childbearing age with RHP and for their longitudinal follow-up.